Results 151 to 160 of about 14,756 (172)

Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice. [PDF]

Eur J Clin Microbiol Infect Dis
Colaneri M, Genovese C, Lombardi A, Holmes D, Bandera A, Gori A.   +5 more
europepmc   +1 more source

Multigram-scale chemoenzymatic synthesis of diverse aminopolycarboxylic acids as potential metallo-β-lactamase inhibitors.

Org Biomol Chem
Bhat MF, Prats Luján A, Saifuddin M, Fodran P, Poelarends GJ.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fluorogenic Probes/Inhibitors of β‐Lactamase and their Applications in Drug‐Resistant Bacteria

Angewandte Chemie - International Edition, 2021
Qiong Wu, Xiamin Cheng, Lin Li
exaly  

Novel metallo-β-lactamase inhibitors

Nature Reviews Microbiology, 2021
exaly  

New β-Lactam–β-Lactamase Inhibitor Combinations

Clinical Microbiology Reviews, 2020
Dafna Yahav, Vincent H Tam, Leonard Leibovici   +2 more
exaly  

Interplay between β-lactamases and new β-lactamase inhibitors

Nature Reviews Microbiology, 2019
Karen Bush, Patricia A Bradford
exaly  

Epidemiology of β-Lactamase-Producing Pathogens

Clinical Microbiology Reviews, 2020
Karen Bush, Patricia A Bradford
exaly  

An update on β-lactamase inhibitor discovery and development

Drug Resistance Updates, 2018
Jean-Denis Docquier, Stefano Mangani
exaly  

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

Journal of Molecular Biology, 2019
Catherine L Tooke, Philip Hinchliffe, James Spencer   +2 more
exaly